|
Clearbridge BioMedics' ClearCell™ CTChip® presented at the Molecular Med Tri-Conference
20 February 2012
Clearbridge BioMedics’ revolutionary ClearCell™ CTChip® will be presented at the Molecular Med Tri-Conference in San Francisco from 19 to 23 February 2012.
Clearbridge BioMedics is partnering with Abnova to distribute its proprietary ClearCell™ System and CTChip®, which Abnova will be marketing as the Abnova Captor System along with its proprietary antibodies and reagents. This product will be showcased during the exhibition, where some 3,000 delegates will have the opportunity to view the Abnova Captor system.
The Abnova Captor system is a platform that provides the next generation, noninvasive liquid biopsy for cancer screening, staging, treatment and monitoring. It is driven by Clearbridge BioMedics’ ClearCell™ CTChip®, an advanced micro-filtration system for isolating and retrieving circulating tumor cells, and also incorporates Abnova’s proprietary antibody reagents, for accurately diagnosing specific medical conditions.
Clearbridge BioMedics partners with companies like Abnova, to distribute its proprietary ClearCell™ CTChip® technology. Clearbridge BioMedics will work with these partners to co-brand and co-market the device, allowing it to reach wider markets.
During the Molecular Med Tri-Conference, Clearbridge BioMedics’ co-founder and inventor, Professor Lim Chwee Teck will be presenting the findings of his research in a talk entitled, "Microfluidic Biochips for the Label-Free Detection, Isolation and Retrieval of Circulating Tumor Cells". Prof Lim is from the Department of Bioengineering and Department of Mechanical Engineering, National University of Singapore.
More information can be found here.
Clearbridge BioMedics' Founder wins prestigious President's Technology Award 2011, Singapore
9 November 2011
Professor Lim Chwee Teck was commended at the annual President's Science and Technology Awards (PSTA) 2011 in Singapore, which are the highest honours bestowed on exceptional research scientists and engineers in Singapore for their excellent achievements in science and technology.
For his outstanding work in developing the novel micro biochip for cancer detection through blood samples (which spun-off into Clearbridge BioMedics), Professor Lim was announced the sole recipient of the prestigious President's Technology Award 2011.
TechVenture 2011, Singapore
13-14 October 2011
Mr Johnson Chen, Clearbridge BioMedics' Founder, was presented the Rising Star Innovator award at TechVenture Asiasons Innovation Awards 2011 held in Marina Bay Sands Expo and Convention Center, Singapore.
News Feature: Clearbridge BioMedics Founders interviewed in The Straits Times Money section.
28 September 2011
Clearbridge BioMedics founders Johnson Chen and Chong Chee Wah were featured in The Straits Times article "'Nerds' fight cancer with med tech"today under Money's SME Spotlight, along with our ClearCell™ Unit and CTChips®.
Click on the image below to view the full news feature article.
Source: Straits Times © Singapore Press Holdings Limited. Reproduced with permission.
Please do not reproduce, distribute, display, sell, publish, broadcast, or circulate or otherwise make the above article or part thereof available in any manner on any media to any third party.
Press Release: Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets
8 September 2011
Clearbridge BioMedics announced today a collaboration, to jointly develop a revolutionary platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring with Abnova.
Abnova will incorporate its proprietary antibody reagents with Clearbridge BioMedics' ClearCell™ CTChip® to enable the accurate diagnosis of specific medical conditions or diseases.
View the Press Release here.
Press Release: Clearbridge Accelerator receives investment from Silicon Valley “Super-Angel”
1 August 2011
Clearbridge Accelerator announced today that it has received an investment from Tim Draper,a well-established venture capitalist based in the Silicon Valley.
Mr Draper, who is the Founder and a Managing Director of Draper Fisher Jurvetson (DFJ), is well known for making early-stage investments in dynamic companies in new markets.
Clearbridge BioMedics is an incubatee under Clearbridge Accelerator.
Download the Press Release (PDF): Singapore technology incubator receives investment from Silicon Valley "Super-Angel"
For more information, email media@clearbridgeaccelerator.com.
World CTC Summit 2011, Hamburg, Germany
Apr. 12th - 14th 2011
Clearbridge BioMedics will have a poster and a representative at the World CTC Summit , Apr. 12-14, 2011, Hamburg, Germany. For more information, email contactus@clearbridgebiomedics.com
American Association for Cancer Research (AACR) 102nd Annual Meeting 2011, Orlando Florida
Apr. 2nd - 6th 2011
Clearbridge BioMedics will be exhibiting at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando Florida. Visit our exhibition at Booth 115 at the Orange Country Convention Center on April 2nd to 6th, 2011. Our representatives there will be happy to answer any questions. For more information, email contactus@clearbridgebiomedics.com
Nature Medicine March 2011 Issue
Mar 2011
Our Technology was recently mentioned in a news article "New technologies aim to take cancer out of circulation" in the Mar 2011 issue of Nature Medicine.
Clearbridge BioMedics News Archive (Year 2009-2010)
TechVenture 2010
Clearbridge BioMedics was chosen as one of the best 20 Start Up companies to be showcased at TechVenture 2010. Presented by National Research Foundation (NRF) and Singapore Venture Capital and Private Equity Association (SVCA), TechVenture 2010 is Asia’s premier event for investors who represent billions of dollars of investment funds ready for deployment into Asia. We were honoured to have our booth visited by Dr Tony Tan, Chairman of the National Research Foundation.
IES Prestigious Engineering Achievement Award 2010
The NUS team behind the CTC Microfiltration BioChip were one of the few selected to receive this prestigious award in light of the outstanding work they conducted on their invention. Congratulations!
News feature
Clearbridge BioMedics and CTC Microfiltration BioChip was featured in The Straits Times on Saturday, June 26 2010, detailing the novel way our device can isolate and retrieve circulating tumour cells in native state. The article includes interviews with eminent oncologists such as Dr Darren Lim from NCCS, currently heading a clinical trial to demonstrate the effectiveness of the BioChip. In addition to complementing current cancer detection methods and research, CTC Microfiltration BioChip, when proven effective, will be one of the few home-grown technologies to be adopted by researchers and clinicians worldwide.
WCC 2010
Clearbridge BioMedics showcased the CTC Microfiltration BioChip at the 3rd World Cancer Congress 2010 at the Singapore Expo this June 22 - 24.
TECS POV Grant
In Nov 2009, Clearbridge BioMedics was proud to be one of the few recipients of SPRING's Technology Enterprise Commercialisation Scheme Proof of Value (TECS POV) grant. This is in recognition of our commitment in translating our innovative and potentially market-disrupting CTC isolation and enumeration technology into commercial viability.
Tan Kah Kee Young Inventors' Award
In recognition of his efforts and innovative approach in CTC isolation and retrieval, Mr Tan Swee Jin was awarded with the Tan Kah Kee Young Inventors' Award in 2009. First set up in 1986, this award is given to young inventors who have created innovations that are original, practical and can be translated into designs of commercial value.
|
